Multiple sclerosis scientist discusses latest research at Feinstein Institute Marsh Lecture

MANHASSET, NY – The Feinstein Institute for Medical Research hosted a Marsh Lecture by Stanford University George A. Zimmerman Professor and Professor of Pediatrics Lawrence Steinman, MD. Dr. Steinman discussed his research into the role amyloid proteins play in slowing immune response in patients with multiple sclerosis (MS).

Amyloid proteins are often thought to be the cause of neurodegenerative diseases like Alzheimer’s disease. Dr. Steinman’s lecture, titled “Amyloids and the Neuro-Immune Connection,” discussed amyloid proteins and how they cause the immune response to slow and reverses paralysis in a mouse model of MS. Based on these findings, he believes amyloid proteins could provide a therapeutic target for MS and other conditions.

“Dr. Steinman is a leader in the field of neuroinflammation, and his basic scientific work led directly to new therapies that have helped thousands”, said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute.

The Feinstein Institute’s Marsh Lecture was established as a forum for renowned scientists to share their expertise with Feinstein Institute investigators. Made possible by an endowment from the late Leonard Marsh and his family, the Marsh Lecture honors the memory of Leonard Marsh, co-founder of Snapple Beverage Corporation and a major supporter of the Feinstein Institute. Leonard Marsh’s legendary enthusiasm for new ideas and innovations continue to inspire the Feinstein Institute scientific faculty and staff.

For more information on this and upcoming Marsh Lectures, click here.

About the Feinstein Institute

The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the Feinstein Institute includes 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit

For media inquiries, please contact:

Heather E. Ball Mayer